Security Snapshot

BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) Institutional Ownership

CUSIP: 09077B104

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

40

Shares (Excl. Options)

13,178,637

Price

$0.57

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stocks, par value $0,0001 per share
Symbol
BCAB on Nasdaq
Shares outstanding
58,548,563
Price per share
$0.16
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
13,178,637
Total reported value
$7,494,979
% of total 13F portfolios
0%
Share change
-103,395
Value change
-$262,374
Number of holders
40
Price from insider filings
$0.16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share is tracked under CUSIP 09077B104.
  • 40 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 40 to 2 between Q4 2025 and Q1 2026.
  • Reported value moved from $7,494,979 to $5,582.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 40 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 09077B104?
CUSIP 09077B104 identifies BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.7% -22% $2,129,415 -$1,104,235 4,839,579 -34% Highbridge Capital Management, LLC 31 Mar 2025
ACORN BIOVENTURES, L.P. 8.3% $2,127,449 4,835,111 Anders Hove 15 May 2025
SHORT JAY M PHD 6.6% $1,700,884 3,865,646 Jay M. Short 31 Dec 2024
OPOKA INVESTMENT FUND Co 4.8% -22% $1,933,227 -$507,296 2,810,331 -21% OPOKA INVESTMENT FUND Co 09 Jul 2025
MILLENNIUM MANAGEMENT LLC 1.9% $482,067 1,095,606 Millennium Management LLC 31 Dec 2024

As of 31 Dec 2025, 40 institutional investors reported holding 13,178,637 shares of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB). This represents 23% of the company’s total 58,548,563 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ACORN CAPITAL ADVISORS, LLC 8.3% 4,835,111 0% 0.93% $2,756,013
VANGUARD GROUP INC 3.3% 1,945,795 0% 0% $1,105,212
MARSHALL WACE, LLP 1.5% 891,580 0% $508,201
MILLENNIUM MANAGEMENT LLC 1.3% 762,394 +123% 0% $432,811
ACADIAN ASSET MANAGEMENT LLC 1.3% 757,671 -19% 0% $429,000
RENAISSANCE TECHNOLOGIES LLC 1.2% 707,214 -12% 0% $401,485
DEUTSCHE BANK AG\ 0.9% 525,353 0% 0% $299,451
GEODE CAPITAL MANAGEMENT, LLC 0.85% 500,328 +1% 0% $284,096
BlackRock, Inc. 0.82% 480,933 0% 0% $273,026
JANE STREET GROUP, LLC 0.59% 346,774 +78% 0% $196,863
UBS Group AG 0.39% 225,684 +160% 0% $128,188
ADAR1 Capital Management, LLC 0.31% 183,107 0.01% $103,950
STATE STREET CORP 0.26% 151,377 0% 0% $85,937
SIMPLEX TRADING, LLC 0.21% 120,391 +233% 0% $68,382
NORTHERN TRUST CORP 0.18% 103,494 +2.6% 0% $58,754
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.14% 81,687 -68% 0% $46,373
TWO SIGMA INVESTMENTS, LP 0.14% 81,330 +100% 0% $46,171
PVG ASSET MANAGEMENT CORP 0.12% 69,000 +3% 0.08% $39,171
XTX Topco Ltd 0.1% 60,395 +212% 0% $34,286
Virtu Financial LLC 0.09% 55,460 0% $31,000
HRT FINANCIAL LP 0.09% 54,742 +26% 0% $31,000
MAI Capital Management 0.09% 51,504 +14% 0% $29,239
MORGAN STANLEY 0.07% 43,653 +183% 0% $24,781
COLUMBIA ADVISORY PARTNERS LLC 0.04% 26,070 0% 0.01% $14,800
COMMONWEALTH EQUITY SERVICES, LLC 0.04% 25,300 0% 0% $14,360

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 35,687 $5,582 -$23,414 $0.16 2
2025 Q4 13,178,637 $7,494,979 -$262,374 $0.57 40
2025 Q3 13,349,032 $9,190,012 +$218,760 $0.69 43
2025 Q2 13,168,921 $5,214,805 -$178,456 $0.40 39
2025 Q1 13,676,589 $4,757,169 -$6,041,757 $0.35 40
2024 Q4 24,014,047 $14,192,960 -$3,984,785 $0.59 67
2024 Q3 17,681,418 $31,044,305 -$6,375,131 $1.76 63
2024 Q2 22,134,924 $30,397,774 -$9,819,957 $1.37 78
2024 Q1 25,353,603 $87,226,850 -$3,078,466 $3.44 83
2023 Q4 27,002,533 $66,550,242 -$6,102,978 $2.46 79
2023 Q3 29,893,256 $50,818,372 -$3,978,003 $1.70 80
2023 Q2 32,003,208 $96,009,836 -$889,082 $3.00 86
2023 Q1 32,818,307 $87,622,240 -$35,920,780 $2.68 79
2022 Q4 33,849,374 $279,248,047 +$75,723,026 $8.25 88
2022 Q3 24,872,441 $191,538,348 +$24,104,114 $7.70 66
2022 Q2 23,517,118 $67,049,000 -$8,813,651 $2.85 71
2022 Q1 25,528,713 $127,715,000 -$39,588,884 $5.00 91
2021 Q4 26,409,935 $518,424,807 +$9,459,769 $19.63 79
2021 Q3 25,357,996 $746,373,968 +$120,415,617 $29.44 83
2021 Q2 21,165,507 $896,994,925 +$89,307,130 $42.38 73
2021 Q1 19,002,884 $964,589,936 +$187,867,257 $50.84 62
2020 Q4 15,664,281 $530,219,000 +$530,219,000 $34.01 53